title: Additive and synergistic interactions of monoclonal antibodies and immunotoxins reactive with breast and ovarian cancer.
authors.affiliation: Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina.
authors.forename: R C
authors.initials: RC
authors.lastname: Bast
authors.forename: F
authors.initials: F
authors.lastname: Xu
authors.forename: Y
authors.initials: Y
authors.lastname: Yu
authors.forename: J
authors.initials: J
authors.lastname: Crews
authors.forename: Y
authors.initials: Y
authors.lastname: Argon
authors.forename: L
authors.initials: L
authors.lastname: Maier
authors.forename: Y
authors.initials: Y
authors.lastname: Lidor
authors.forename: A
authors.initials: A
authors.lastname: Berchuck
authors.forename: C M
authors.initials: CM
authors.lastname: Boyer
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001943:Breast Neoplasms / Q000276:immunology* / Q000628:therapy; D066246:ErbB Receptors / Q000032:analysis / Q000276:immunology; D005260:Female; D006801:Humans; D000922:Immunotoxins / Q000494:pharmacology*; D051379:Mice; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy; D011518:Proto-Oncogene Proteins / Q000032:analysis / Q000276:immunology; D018719:Erb-b2 Receptor Tyrosine Kinases
chemical_list: D000911:Antibodies, Monoclonal; D066246:ErbB Receptors; D000922:Immunotoxins; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases